Mitogen-activated protein kinase kinases promote mitochondrial biogenesis in part through inducing peroxisome proliferator-activated receptor γ coactivator-1β expression

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 6, 2011, Pages 1239-1244

  Gao, Minghui ^a   Wang, Junjian ^a   Lu, Na ^a   Fang, Fang ^a   Liu, Jinsong ^a   Wong, Chi Wai ^b  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b NeuMed Pharmaceuticals Limited   (Hong Kong)

Author keywords

MEK1 2; Mitochondrial biogenesis; PGC 1

Indexed keywords

CYTOCHROME C; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

BLOTTING, WESTERN; BUTADIENES; CARRIER PROTEINS; CELL LINE, TUMOR; CYTOCHROMES C; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 79955658662     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.03.017     Document Type: Article

References (24)

1. McKay M.M., Morrison D.K. Integrating signals from RTKs to ERK/MAPK. Oncogene 2007, 26:3113-3121.
2. Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310.
3. Monick M.M., Powers L.S., Barrett C.W., Hinde S., Ashare A., Groskreutz D.J., Nyunoya T., Coleman M., Spitz D.R., Hunninghake G.W. Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J. Immunol. 2008, 180:7485-7496.
4. Flynn J.M., Lannigan D.A., Clark D.E., Garner M.H., Cammarata P.R. RNA suppression of ERK2 leads to collapse of mitochondrial membrane potential with acute oxidative stress in human lens epithelial cells. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E589-E599.
5. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 2008, 29:677-696.
6. Handschin C., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006, 27:728-735.
7. Dufour C.R., Wilson B.J., Huss J.M., Kelly D.P., Alaynick W.A., Downes M., Evans R.M., Blanchette M., Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERR[alpha] and [gamma]. Cell Metab. 2007, 5:345-356.
8. Wang Y., Fang F., Wong C.W. Troglitazone is an estrogen-related receptor alpha and gamma inverse agonist. Biochem. Pharmacol. 2010, 80:80-85.
9. Wu F., Wang J., Wang Y., Kwok T.-T., Kong S.-K., Wong C. Estrogen-related receptor [alpha] (ERR[alpha]) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells. Chem. Biol. Interact. 2009, 181:236-242.
10. Wang W., Wong C.W. Statins enhance peroxisome proliferator-activated receptor gamma coactivator-1alpha activity to regulate energy metabolism. J. Mol. Med. 2010, 88:309-317.
11. Liao X., Wang Y., Wong C.W. Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor gamma co-activator-1alpha protein. Br. J. Pharmacol. 2010, 161:771-781.
12. Huang Z., Fang F., Wang J., Wong C.W. Structural activity relationship of flavonoids with estrogen-related receptor gamma. FEBS Lett. 2010, 584:22-26.
13. Xu J., Liao X., Wong C. Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int. J. Cancer 2010, 126:1029-1035.
14. Wang J., Fang F., Huang Z., Wang Y., Wong C. Kaempferol is an estrogen-related receptor [alpha] and [gamma] inverse agonist. FEBS Lett. 2009, 583:643-647.
15. Gopalbhai K., Jansen G., Beauregard G., Whiteway M., Dumas F., Wu C., Meloche S. Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1. J. Biol. Chem. 2003, 278:8118-8125.
16. Sankaran V.G., Orkin S.H., Walkley C.R. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 2008, 22:463-475.
17. Matoba S., Kang J.-G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
18. Barry J.B., Giguere V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor {alpha}. Cancer Res. 2005, 65:6120-6129.
19. Echave P., Machado-da-Silva G., Arkell R.S., Duchen M.R., Jacobson J., Mitter R., Lloyd A.C. Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. J. Cell Sci. 2009, 122:4516-4525.
20. Stein R.A., McDonnell D.P. Estrogen-related receptor alpha as a therapeutic target in cancer. Endocr. Relat. Cancer 2006, 13(Suppl 1):S25-S32.
21. Chisamore M.J., Wilkinson H.A., Flores O., Chen J.D. Estrogen-related receptor-{alpha} antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol. Cancer Ther. 2009, 8:672-681.
22. Bianco S., Lanvin O., Tribollet V., Macari C., North S., Vanacker J.M. Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J. Biol. Chem. 2009, 284:23286-23292.
23. Wang J., Wang Y., Wong C. Oestrogen-related receptor alpha inverse agonist XCT-790 arrests A549 lung cancer cell population growth by inducing mitochondrial reactive oxygen species production. Cell Prolif. 2010, 43:103-113.
24. Yu S., Wang X., Ng C.-F., Chen S., Chan F.L. ERR{gamma} suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer Res. 2007, 67:4904-4914.